Cargando…
Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
Autores principales: | De Kleijn, Kim M. A., Martens, Gerard J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343297/ https://www.ncbi.nlm.nih.gov/pubmed/33642388 http://dx.doi.org/10.4103/1673-5374.308088 |
Ejemplares similares
-
Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999) -
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013) -
Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020) -
Activation of Nuclear Factor-kappa B signalling promotes cellular senescence
por: Rovillain, Emilie, et al.
Publicado: (2011) -
Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway
por: Hershberger, Paul M, et al.
Publicado: (2013)